Humana Announces Management Team Appointments
January 29 2019 - 11:00AM
Business Wire
Promotes Joseph Ventura to General
Counsel
Names Douglas Stoss Interim Lead for the
Office of Corporate Affairs
Humana Inc. (NYSE: HUM), one of the nation’s leading health and
well-being companies, announced today two key strategic leadership
appointments in anticipation of upcoming transitions. The company
promoted Joseph Ventura to General Counsel and named Douglas Stoss
interim lead for Humana’s Office of Corporate Affairs. Both will
report to Humana President and CEO Bruce Broussard and serve as
members of the company’s Management Team.
Ventura succeeds Christopher Todoroff, who has announced his
retirement after a career in corporate law that spans three
decades, including the past 10 years with Humana as General Counsel
and Chief Legal Officer.
Ventura joined Humana as Legal Counsel in 2009, serving most
recently as Senior Vice President, Associate General Counsel and
Corporate Secretary, and has worked directly with the Board of
Directors on significant M&A and securities law matters, while
also leading the Law Department’s Corporate Group. Ventura and
Todoroff will work together over the next several months to ensure
a smooth transition, during which time Todoroff will serve as
Special Counsel to the Company.
“Joe is a seasoned corporate and M&A legal strategist whose
central involvement in our strategic acquisitions has afforded him
a broad enterprise view of Humana’s business, including strategic
litigation, enterprise risk issues, and a broad range of regulatory
and public affairs matters,” said Broussard. “His ability to
communicate and collaborate effectively across the organization has
made him a highly sought advisor by the senior leadership
team.”
Broussard also praised Todoroff’s legal and strategic acumen.
“For a decade, Chris has shaped the company’s legal strategy,
making it possible for Humana to expand its clinical capabilities
to help the people we serve achieve their best health through an
integrated care delivery model that personalizes and simplifies the
health care experience.”
Prior to joining Humana, Ventura was an associate in the New
York office of Alston & Bird LLP, concentrating his practice in
securities regulation and compliance, mergers and acquisitions,
including domestic/cross-border and public/private business
combinations, as well as Sarbanes-Oxley and other corporate
governance matters. Ventura received his bachelor’s degree in
political science and international relations from the University
of Richmond and his law degree from the University of Virginia.
In addition, Douglas Stoss will serve as interim lead of the
Office of Corporate Affairs as Humana continues its comprehensive
internal and external search for a successor to Chief Corporate
Affairs Officer Heidi Margulis, who announced her intention last
year to transition from the company in the course of 2019 after 33
years of distinguished service. Since joining Humana in 2014, Stoss
has led the company’s Washington, D.C. office, helping Humana
navigate the federal legislative and regulatory landscape.
“Doug is a strong leader and highly accomplished government
affairs practitioner,” said Broussard. “He brings extensive
business, executive and legislative branch experience to this
assignment, and I’m confident in his ability to continue to advance
Humana’s point of view on health care quality, access and
affordability with governments at all levels.”
Broussard also recognized Margulis and her many contributions to
the organization. “In the course of her remarkable career, Heidi
has helped refocus our company’s public sector strategies from
short-term priorities to long-term initiatives to create a
competitive advantage in the marketplace by removing barriers to
more affordable, quality benefits and services for consumers,
especially those in greatest need. In addition, she has increased
Humana’s impact in the communities we serve by aligning our
community-focused initiatives across the enterprise. This work
included guiding the company's community outreach,
coalition-building activities and corporate social responsibility
initiatives, as well as administrative oversight of the Humana
Foundation.” Margulis will remain a member of the Humana
Foundation Board of Directors.
Stoss joined Humana from Bristol-Myers Squibb, where he served
for five years as Director of Market Access Strategy, responsible
for shaping the company’s strategy for public-sector activities.
Previously, Stoss served as Chief of Staff at the Centers for
Medicare and Medicaid Services (CMS) during the period when CMS
launched multiple quality initiatives, the Medicare Prescription
Drug Program (PDP) and expanded the Medicare Advantage (MA)
program. In the legislative branch, he served in several leadership
positions for former U.S. Rep. John Shadegg (R-Ariz.) and started
his public service working for U.S. Sen. Susan Collins (R-Maine).
Stoss earned his bachelor’s degree in political science from the
University of Arizona.
About Humana
Humana Inc. is committed to helping our millions of medical and
specialty members achieve their best health. Our successful history
in care delivery and health plan administration is helping us
create a new kind of integrated care with the power to improve
health and well-being and lower costs. Our efforts are leading to a
better quality of life for people with Medicare, families,
individuals, military service personnel, and communities at
large.
To accomplish that, we support physicians and other health care
professionals as they work to deliver the right care in the right
place for their patients, our members. Our range of clinical
capabilities, resources and tools – such as in-home care,
behavioral health, pharmacy services, data analytics and wellness
solutions – combine to produce a simplified experience that makes
health care easier to navigate and more effective.
More information regarding Humana is available to investors via
the Investor Relations page of the company’s web site at
www.humana.com, including copies of:
- Annual reports to stockholders
- Securities and Exchange Commission
filings
- Most recent investor conference
presentations
- Quarterly earnings news releases and
conference calls
- Calendar of events
- Corporate Governance information
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190129005643/en/
Mark MathisHumana Corporate Communications(312)
441-5010mmathis@humana.com
Amy SmithHumana Investor Relations(502)
580-2811amysmith@humana.com
Humana (NYSE:HUM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Humana (NYSE:HUM)
Historical Stock Chart
From Jul 2023 to Jul 2024